Metabolic Investigation of Human Breast Cancer Cells
The Skildum lab researches metabolic changes that lead to drug resistance in breast cancer. Although there are effective treatments for breast cancer, the development of drug resistance limits their clinical benefit. By comparing the metabolism of drug resistant and drug sensitive breast cancer cells, these researchers will identify pathways and novel diagnostic or therapeutic targets to improve clinical outcomes for breast cancer patients.
Return to this PI's main page.